SCHEMBL8522702

SCHEMBL8522702

CN1CCN(CC2CCC(Nc3ncc4ncnc(Nc5ccc(F)c(Cl)c5)c4n3)CC2)CC1

nearest known ligand 0.80

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
EGFR P00533 15/20 0.80
ERBB2 P04626 5/20 0.80
HPGD P15428 1/20 0.80
HTT P42858 1/20 0.80
MAPT P10636 1/20 0.54
AXL P30530 2/20 0.51
BCL6 P41182 1/20 0.49
ERBB4 Q15303 2/20 0.48
JAK3 P52333 1/20 0.48
CSNK2A1 P68400 1/20 0.48
MELK Q14680 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6995583 0.93 EGFR (0.73) EGFRERBB2HPGDHTTMAPT
SCHEMBL8317916 0.92 EGFR (0.72) EGFRERBB2HPGDHTTMAPT
SCHEMBL6995293 0.91 EGFR (0.70) EGFRERBB2HPGDHTTMAPT
SCHEMBL8486069 0.91 EGFR (0.70) EGFRERBB2HPGDHTTMAPT
SCHEMBL6993837 0.91 EGFR (0.70) EGFRERBB2HPGDHTTMAPT
SCHEMBL8486251 0.90 EGFR (0.69) EGFRERBB2HPGDHTTMAPT
Falnidamol SCHEMBL158563 0.89 EGFR (1.00) EGFRERBB2HPGDHTTMAPT
Falnidamol SCHEMBL29387986 0.89 EGFR (1.00) EGFRERBB2HPGDHTTMAPT
Falnidamol SCHEMBL29409569 0.88 EGFR (0.98) EGFRERBB2HPGDHTTMAPT
Falnidamol SCHEMBL29403789 0.88 EGFR (0.98) EGFRERBB2HPGDHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888351-A1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-01-07 EP disclosed
WO-1997032880-A1 PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO disclosed